Skip to main content
Book Chapter

Recurrent Stroke Prevention: Diuretic and Angiotensin-Converting Enzyme Inhibitors (ACEIs)—The PROGRESS Trial

  • Linden T
  • Donnan G
Springer International Publishing, (2016), 215-231
DOI: 10.1007/978-3-319-29152-9_12
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

… five patients are intolerant to ACEI, there was hope that ARB … protection by the ACEI + ARB combination, that ARB was better … It failed, however, to show any effect of the combination …

Cite

CITATION STYLE

APA

Linden, T. K. A., & Donnan, G. A. (2016). Recurrent Stroke Prevention: Diuretic and Angiotensin-Converting Enzyme Inhibitors (ACEIs)—The PROGRESS Trial. In Hypertension and Stroke (pp. 215–231). Springer International Publishing. https://doi.org/10.1007/978-3-319-29152-9_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free